The analysis of the liver functioning through
bilurbin dosage has been up on fifty blood donors. The reactive bandages have
been used to seek bilurbines in the
urines of those patients considered as carriers with HBV and HCV. After
analysis, this descriptive study has shown that out of 31 cases found at men more
than 25 years old, 27 cases whose livers don’t function present a
hyper degree of bilurbine when there is hepatitis. The doorstep of 3.9 μmol/L hold 65.2% of
hepatitis B and hepatitis C. Whereas at the doorstep of 1.5 μmol/L and 7.8 μmol/L, the HBV has got
respectively 8.7% and 26.1% of cases; and HCV has also got 33.3% and 26.7% of
cases.
Cite this paper
Ndaya, K. A. , Kamb, A. M. R. , Kalenga, M. P. , Manji, I. C. and Mwinkeu, K. N. (2017). Investigation of Hepatitis Functioning through Bilurbin at Blood Donors with HBV and HCV Positive. Open Access Library Journal, 4, e4166. doi: http://dx.doi.org/10.4236/oalib.1104166.
National Committee for Clinical Laboratory Standard (1992) Routine Analysis and Collection Transportation and Preservation of Urine Specimens. Tentative Guideline, 12, 26.
Ngo Sack, F., Noah Noah, D., Zouhairatou, H., et al. (2013) Prevalence of HBs Antigen and Anti-HCV Antibodies in Homozygous Sickle Cell at Yaounde Central Hospital. The Pan African Medical Journal, 14, 40.
Habou Akilou, H. (2009) Study of the Prevalences of ANTI-HCV and HBS Antigens Using Data from the Microbiology Laboratory and the Gastroenterology Department of Ibn Sina Hospital in Rabat. http://hdl.handle.net/
Elzouki, A.N., Smeo, M.N., Sammud, M., Elahmer, O., Daw, M., Furarah, A., Abudher, A. and Mohamed, M.K. (2013) Prevalence of Hepatitis B and C Virus Infections and Associated Risk Factors in Libya: National Sero-Epidemiological Survey. The Eastern Mediterranean Health Journal, 19, 589-599. https://www.ncbi.nlm.nih.gov/pubmed
Durand, F., Danic, B., Tardivel, R., Semana, G., Gouezec, H., Martinot, M., Marcellin, P. and Beauplet, A. (2000) Discovery of a Chronic Infection by HCV without Seroconversion in a Blood Donor in France during 28 Months. Clinical and Biological Transfusion, 7, 242-250.